advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (15)
Showing records 1 to 15
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation56364 In Vivo Laser Scanning Confocal Microscopy of the Ocular Surface in Glaucoma
Mastropasqua L; Agnifili L; Mastropasqua R; Fasanella V; Nubile M; Toto L; Carpineto P; Ciancaglini M
Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada 2014; 0: 1-16
56656 Managing adverse effects of glaucoma medications
Inoue K
Clinical Ophthalmology 2014; 8: 903-913
56427 Confocal microscopy of epithelial and langerhans cells of the cornea in patients using travoprost drops containing two different preservatives
Marsovszky L; Resch MD; Visontai Z; Németh J
Pathology oncology research : POR 2014; 20: 741-746
56088 Sustained drug release in nanomedicine: a long-acting nanocarrier-based formulation for glaucoma
Natarajan JV; Darwitan A; Barathi VA; Ang M; Htoon HM; Boey F; Tam KC; Wong TT; Venkatraman SS
ACS nano 2014; 8: 419-429
56517 A temperature-induced and shear-reversible assembly of latanoprost-loaded amphiphilic chitosan colloids: Characterization and in vivo glaucoma treatment
Hsiao MH; Chiou SH; Larsson M; Hung KH; Wang YL; Liu CJ; Liu DM
Acta biomaterialia 2014; 10: 3188-3196
56644 Drug-induced corneal damage
Prescrire International 2014; 23: 97-100
56188 Sustained drug delivery in glaucoma
Knight OJ; Lawrence SD
Current Opinions in Ophthalmology 2014; 25: 112-117
56537 An update on intravitreal implants in use for eye disorders
Lambiase A; Abdolrahimzadeh S; Recupero SM
Drugs of Today 2014; 50: 239-249
56493 Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial
Goldberg I; Gil Pina R; Lanzagorta-Aresti A; Schiffman RM; Liu C; Bejanian M
British Journal of Ophthalmology 2014; 98: 926-931
56243 Diamond nanogel-embedded contact lenses mediate lysozyme-dependent therapeutic release
Kim HJ; Zhang K; Moore L; Ho D
ACS nano 2014; 8: 2998-3005
56313 Mechanism - Based Translational Pharmacokinetic - Pharmacodynamic Model to Predict Intraocular Pressure Lowering Effect of Drugs in Patients with Glaucoma or Ocular Hypertension
Durairaj C; Shen J; Cherukury M
Pharmaceutical Research 2014; 31: 2095-2106
56289 Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits
Ameeduzzafar ; Ali J; Bhatnagar A; Kumar N; Ali A
International Journal of Biological Macromolecules 2014; 65: 479-491
56514 Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo
Tuomela A; Liu P; Puranen J; Rönkkö S; Laaksonen T; Kalesnykas G; Oksala O; Ilkka J; Laru J; Järvinen K; Hirvonen J; Peltonen L
International Journal of Pharmaceutics 2014; 467: 34-41
56624 The PEG-PCL-PEG Hydrogel as an Implanted Ophthalmic Delivery System after Glaucoma Filtration Surgery; a Pilot Study
Peng R; Qin G; Li X; Lv H; Qian Z; Yu L
Medical hypothesis, discovery and innovation in ophthalmology 2014; 3: 3-8
56641 Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease
Alves M; Reinach PS; Paula JS; Vellasco E Cruz AA; Bachette L; Faustino J; Aranha FP; Vigorito A; de Souza CA; Rocha EM
PLoS ONE 2014; 9: e97921